Nevanac

— THERAPEUTIC DISORDERS TREATED —
  • Ocular allergy/inflammation

Nevanac Generic Name & Formulations

General Description

Nepafenac 0.1%, oph. susp; contains benzalkonium chloride.

Pharmacological Class

NSAID.

How Supplied

Susp—3mL

Nevanac Indications

Indications

Post-operative pain and inflammation following cataract surgery.

Nevanac Dosage and Administration

Adult

≥10yrs: 1 drop in affected eye(s) 3 times daily starting one day before surgery, continued on day of surgery, and through first 2 weeks post-op.

Children

<10yrs: not established.

Nevanac Contraindications

Not Applicable

Nevanac Boxed Warnings

Not Applicable

Nevanac Warnings/Precautions

Warnings/Precautions

Bleeding tendencies. May delay wound healing. Complicated/repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used more than 24 hours before surgery, or beyond 14 days post-op. Contact lenses (remove during therapy). Pregnancy (Cat.C; avoid during 3rd trimester). Nursing mothers.

Nevanac Pharmacokinetics

See Literature

Nevanac Interactions

Interactions

Caution with concomitant medications that may prolong bleeding time. Increased potential for healing problems with concomitant topical steroids.

Nevanac Adverse Reactions

Adverse Reactions

Ocular effects (eg, capsular opacity, decreased visual acuity, foreign body sensation, increased intraocular pressure, sticky sensation, edema, dry eye, lid margin crusting, discomfort, hyperemia, pain, pruritus, photophobia, tearing, vitreous detachment), headache, hypertension, GI upset, sinusitis.

Nevanac Clinical Trials

See Literature

Nevanac Note

Not Applicable

Nevanac Patient Counseling

See Literature

Images